Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Up 100.0% in March

Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSE:I) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,000 shares, an increase of 100.0% from the February 29th total of 500 shares. Based on an average daily volume of 4,400 shares, the days-to-cover ratio is currently 0.2 days.

Intellipharmaceutics International Price Performance

OTCMKTS IPCIF traded up $0.01 on Thursday, reaching $0.07. The company had a trading volume of 103 shares, compared to its average volume of 16,541. Intellipharmaceutics International has a 1 year low of $0.00 and a 1 year high of $0.11. The firm has a 50-day moving average of $0.05 and a 200-day moving average of $0.06. The firm has a market capitalization of $2.35 million, a PE ratio of -0.44 and a beta of 1.00.

Intellipharmaceutics International Company Profile

Intellipharmaceutics International Inc, a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain.